Logo image of HLNE

HAMILTON LANE INC-CLASS A (HLNE) Stock Fundamental Analysis

NASDAQ:HLNE - US4074971064 - Common Stock

156.75 USD
+6.89 (+4.6%)
Last: 8/22/2025, 8:13:48 PM
156.75 USD
0 (0%)
After Hours: 8/22/2025, 8:13:48 PM
Fundamental Rating

6

Taking everything into account, HLNE scores 6 out of 10 in our fundamental rating. HLNE was compared to 238 industry peers in the Capital Markets industry. HLNE has an excellent profitability rating, but there are some minor concerns on its financial health. HLNE is valued quite expensively, but it does show have an excellent growth rating. This makes HLNE very considerable for growth investing!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year HLNE was profitable.
In the past year HLNE had a positive cash flow from operations.
In the past 5 years HLNE has always been profitable.
In the past 5 years HLNE always reported a positive cash flow from operatings.
HLNE Yearly Net Income VS EBIT VS OCF VS FCFHLNE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

1.2 Ratios

HLNE has a better Return On Assets (12.86%) than 93.67% of its industry peers.
Looking at the Return On Equity, with a value of 30.31%, HLNE belongs to the top of the industry, outperforming 94.94% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 20.84%, HLNE belongs to the top of the industry, outperforming 97.89% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for HLNE is significantly above the industry average of 7.58%.
Industry RankSector Rank
ROA 12.86%
ROE 30.31%
ROIC 20.84%
ROA(3y)11.28%
ROA(5y)10.68%
ROE(3y)28.1%
ROE(5y)33.18%
ROIC(3y)22.58%
ROIC(5y)19.69%
HLNE Yearly ROA, ROE, ROICHLNE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80 100

1.3 Margins

HLNE has a Profit Margin of 30.49%. This is in the better half of the industry: HLNE outperforms 75.11% of its industry peers.
In the last couple of years the Profit Margin of HLNE has grown nicely.
HLNE has a Operating Margin of 44.40%. This is in the better half of the industry: HLNE outperforms 76.79% of its industry peers.
In the last couple of years the Operating Margin of HLNE has remained more or less at the same level.
Industry RankSector Rank
OM 44.4%
PM (TTM) 30.49%
GM N/A
OM growth 3Y-1.19%
OM growth 5Y0.87%
PM growth 3Y-8.59%
PM growth 5Y6.57%
GM growth 3YN/A
GM growth 5YN/A
HLNE Yearly Profit, Operating, Gross MarginsHLNE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

6

2. Health

2.1 Basic Checks

The number of shares outstanding for HLNE has been increased compared to 1 year ago.
HLNE has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, HLNE has a worse debt to assets ratio.
HLNE Yearly Shares OutstandingHLNE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
HLNE Yearly Total Debt VS Total AssetsHLNE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

An Altman-Z score of 6.85 indicates that HLNE is not in any danger for bankruptcy at the moment.
The Altman-Z score of HLNE (6.85) is better than 89.45% of its industry peers.
HLNE has a debt to FCF ratio of 1.01. This is a very positive value and a sign of high solvency as it would only need 1.01 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 1.01, HLNE belongs to the top of the industry, outperforming 89.45% of the companies in the same industry.
HLNE has a Debt/Equity ratio of 0.40. This is a healthy value indicating a solid balance between debt and equity.
HLNE's Debt to Equity ratio of 0.40 is fine compared to the rest of the industry. HLNE outperforms 69.62% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF 1.01
Altman-Z 6.85
ROIC/WACCN/A
WACCN/A
HLNE Yearly LT Debt VS Equity VS FCFHLNE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

2.3 Liquidity

A Current Ratio of 1.16 indicates that HLNE should not have too much problems paying its short term obligations.
HLNE has a Current ratio (1.16) which is comparable to the rest of the industry.
HLNE has a Quick Ratio of 1.16. This is a normal value and indicates that HLNE is financially healthy and should not expect problems in meeting its short term obligations.
HLNE's Quick ratio of 1.16 is in line compared to the rest of the industry. HLNE outperforms 53.16% of its industry peers.
Industry RankSector Rank
Current Ratio 1.16
Quick Ratio 1.16
HLNE Yearly Current Assets VS Current LiabilitesHLNE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

8

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 7.80% over the past year.
The Earnings Per Share has been growing by 20.18% on average over the past years. This is a very strong growth
The Revenue has grown by 28.73% in the past year. This is a very strong growth!
HLNE shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 21.08% yearly.
EPS 1Y (TTM)7.8%
EPS 3Y4.79%
EPS 5Y20.18%
EPS Q2Q%-13.25%
Revenue 1Y (TTM)28.73%
Revenue growth 3Y24.67%
Revenue growth 5Y21.08%
Sales Q2Q%-10.56%

3.2 Future

HLNE is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.23% yearly.
The Revenue is expected to grow by 14.19% on average over the next years. This is quite good.
EPS Next Y-0.5%
EPS Next 2Y8.96%
EPS Next 3Y11.23%
EPS Next 5YN/A
Revenue Next Year8.46%
Revenue Next 2Y11.7%
Revenue Next 3Y14.19%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
HLNE Yearly Revenue VS EstimatesHLNE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M 1B
HLNE Yearly EPS VS EstimatesHLNE Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 32.39, HLNE can be considered very expensive at the moment.
HLNE's Price/Earnings ratio is a bit more expensive when compared to the industry. HLNE is more expensive than 71.73% of the companies in the same industry.
HLNE's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.24.
Based on the Price/Forward Earnings ratio of 26.19, the valuation of HLNE can be described as expensive.
66.67% of the companies in the same industry are cheaper than HLNE, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.81, HLNE is valued at the same level.
Industry RankSector Rank
PE 32.39
Fwd PE 26.19
HLNE Price Earnings VS Forward Price EarningsHLNE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

HLNE's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. HLNE is cheaper than 65.82% of the companies in the same industry.
HLNE's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 30.24
EV/EBITDA 26.83
HLNE Per share dataHLNE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

HLNE has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1.6
EPS Next 2Y8.96%
EPS Next 3Y11.23%

4

5. Dividend

5.1 Amount

HLNE has a Yearly Dividend Yield of 1.44%.
Compared to an average industry Dividend Yield of 8.00, HLNE is paying slightly less dividend.
Compared to the average S&P500 Dividend Yield of 2.34, HLNE is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.44%

5.2 History

The dividend of HLNE is nicely growing with an annual growth rate of 19.56%!
HLNE has been paying a dividend for over 5 years, so it has already some track record.
HLNE has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)19.56%
Div Incr Years7
Div Non Decr Years7
HLNE Yearly Dividends per shareHLNE Yearly Dividends per shareYearly Dividends per share 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

HLNE pays out 34.95% of its income as dividend. This is a sustainable payout ratio.
The dividend of HLNE is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP34.95%
EPS Next 2Y8.96%
EPS Next 3Y11.23%
HLNE Yearly Income VS Free CF VS DividendHLNE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
HLNE Dividend Payout.HLNE Dividend Payout, showing the Payout Ratio.HLNE Dividend Payout.PayoutRetained Earnings

HAMILTON LANE INC-CLASS A

NASDAQ:HLNE (8/22/2025, 8:13:48 PM)

After market: 156.75 0 (0%)

156.75

+6.89 (+4.6%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)08-05 2025-08-05/bmo
Earnings (Next)11-04 2025-11-04/bmo
Inst Owners104.24%
Inst Owner Change-8.62%
Ins Owners7.12%
Ins Owner Change0.41%
Market Cap8.73B
Analysts49.09
Price Target166.06 (5.94%)
Short Float %6.38%
Short Ratio4.06
Dividend
Industry RankSector Rank
Dividend Yield 1.44%
Yearly Dividend1.38
Dividend Growth(5Y)19.56%
DP34.95%
Div Incr Years7
Div Non Decr Years7
Ex-Date09-19 2025-09-19 (0.54)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.33%
Min EPS beat(2)1.1%
Max EPS beat(2)11.55%
EPS beat(4)3
Avg EPS beat(4)11%
Min EPS beat(4)-3.63%
Max EPS beat(4)34.99%
EPS beat(8)5
Avg EPS beat(8)6.73%
EPS beat(12)8
Avg EPS beat(12)8.94%
EPS beat(16)12
Avg EPS beat(16)12.74%
Revenue beat(2)2
Avg Revenue beat(2)9.07%
Min Revenue beat(2)4.44%
Max Revenue beat(2)13.69%
Revenue beat(4)3
Avg Revenue beat(4)10.27%
Min Revenue beat(4)-3.38%
Max Revenue beat(4)26.31%
Revenue beat(8)5
Avg Revenue beat(8)8.43%
Revenue beat(12)7
Avg Revenue beat(12)11%
Revenue beat(16)8
Avg Revenue beat(16)7.79%
PT rev (1m)3.26%
PT rev (3m)5.03%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-14.7%
EPS NY rev (1m)9.85%
EPS NY rev (3m)3%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.04%
Revenue NY rev (1m)6.06%
Revenue NY rev (3m)6.63%
Valuation
Industry RankSector Rank
PE 32.39
Fwd PE 26.19
P/S 12.24
P/FCF 30.24
P/OCF 29.01
P/B 12.17
P/tB 12.17
EV/EBITDA 26.83
EPS(TTM)4.84
EY3.09%
EPS(NY)5.98
Fwd EY3.82%
FCF(TTM)5.18
FCFY3.31%
OCF(TTM)5.4
OCFY3.45%
SpS12.8
BVpS12.88
TBVpS12.88
PEG (NY)N/A
PEG (5Y)1.6
Profitability
Industry RankSector Rank
ROA 12.86%
ROE 30.31%
ROCE 24.91%
ROIC 20.84%
ROICexc 26.65%
ROICexgc 27.46%
OM 44.4%
PM (TTM) 30.49%
GM N/A
FCFM 40.49%
ROA(3y)11.28%
ROA(5y)10.68%
ROE(3y)28.1%
ROE(5y)33.18%
ROIC(3y)22.58%
ROIC(5y)19.69%
ROICexc(3y)26.87%
ROICexc(5y)22.9%
ROICexgc(3y)28.19%
ROICexgc(5y)23.88%
ROCE(3y)26.99%
ROCE(5y)23.55%
ROICexcg growth 3Y19.01%
ROICexcg growth 5Y-5.25%
ROICexc growth 3Y19.07%
ROICexc growth 5Y-4.68%
OM growth 3Y-1.19%
OM growth 5Y0.87%
PM growth 3Y-8.59%
PM growth 5Y6.57%
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF 1.01
Debt/EBITDA 0.89
Cap/Depr 130.92%
Cap/Sales 1.71%
Interest Coverage 30.44
Cash Conversion 92.32%
Profit Quality 132.77%
Current Ratio 1.16
Quick Ratio 1.16
Altman-Z 6.85
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)109.9%
Cap/Depr(5y)192.46%
Cap/Sales(3y)1.53%
Cap/Sales(5y)2.53%
Profit Quality(3y)135.75%
Profit Quality(5y)139.47%
High Growth Momentum
Growth
EPS 1Y (TTM)7.8%
EPS 3Y4.79%
EPS 5Y20.18%
EPS Q2Q%-13.25%
EPS Next Y-0.5%
EPS Next 2Y8.96%
EPS Next 3Y11.23%
EPS Next 5YN/A
Revenue 1Y (TTM)28.73%
Revenue growth 3Y24.67%
Revenue growth 5Y21.08%
Sales Q2Q%-10.56%
Revenue Next Year8.46%
Revenue Next 2Y11.7%
Revenue Next 3Y14.19%
Revenue Next 5YN/A
EBIT growth 1Y28.8%
EBIT growth 3Y23.2%
EBIT growth 5Y22.13%
EBIT Next Year-0.77%
EBIT Next 3Y14%
EBIT Next 5YN/A
FCF growth 1Y162.95%
FCF growth 3Y21.48%
FCF growth 5Y21.24%
OCF growth 1Y148.92%
OCF growth 3Y21.07%
OCF growth 5Y20.91%